Science Explorer Back to mapMap
Discussion
Hospital / health system · Salt Lake City · United States

Utah Cancer Specialists

utahcancer.comROR OpenAlex
Research works
45
▲ 86% vs 2018-21
Citations
1.1k
25.3 per fractional work
Top-10% rate
6.1%
all institutions 10.0%
Open access
46%
world 40%
International
11%
world 18%
Utah Cancer Specialists

Not ranked overall: Utah Cancer Specialists is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Utah Cancer Specialists work in?

In all years, 76% of research at Utah Cancer Specialists is in Health Sciences, 11% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (9%), Social Sciences (3%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 75.8% of its workMedicine: 33 fractional works · 73.3% of its workOncology: 6 fractional works · 13.1% of its workPulmonary and Respiratory Medicine: 3 fractional works · 7.8% of its workSurgery: 3 fractional works · 7.2% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 6.7% of its workPhysiology: 2 fractional works · 5.1% of its workEpidemiology: 2 fractional works · 4.5% of its workGenetics: 2 fractional works · 4.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 3.1% of its workPathology and Forensic Medicine: 1 fractional works · 2.2% of its workOrthopedics and Sports Medicine: 1 fractional works · 2.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.9% of its workNephrology: 1 fractional works · 1.9% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.7% of its workRheumatology: 1 fractional works · 1.5% of its workHematology: 1 fractional works · 1.5% of its workDermatology: 1 fractional works · 1.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.2% of its workNeurology: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.0% of its workObstetrics and Gynecology: 0 fractional works · 0.9% of its workReproductive Medicine: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.0% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.7% of its workOral Surgery: 0 fractional works · 0.4% of its workOrthodontics: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.0% of its workLife Sciences: 5 fractional works · 11.0% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 9.5% of its workMolecular Biology: 2 fractional works · 5.1% of its workGenetics: 1 fractional works · 3.2% of its workCancer Research: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.7% of its workMicrobiology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 8.0% of its workEngineering: 1 fractional works · 3.1% of its workBiomedical Engineering: 1 fractional works · 2.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMathematics: 1 fractional works · 2.2% of its workModeling and Simulation: 1 fractional works · 2.2% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workSoftware: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 0 fractional works · 0.7% of its workRadiation: 0 fractional works · 0.7% of its workChemical Engineering: 0 fractional works · 0.4% of its workBioengineering: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.2% of its workBiomaterials: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 5.2% of its workSocial Sciences: 1 fractional works · 3.3% of its workHealth: 1 fractional works · 2.4% of its workLaw: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.8% of its workSocial Psychology: 0 fractional works · 0.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workAccounting: 0 fractional works · 0.4% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKUtah CancerSpecialists45fractional works, all years
Life Sciences11%Physical Sciences8%Health Sciences76%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Medicine3373.3%
    2. Health Professions11.5%
    3. Dentistry00.7%
    4. Nursing00.2%
    5. Veterinary00.0%
    1. Biochemistry, Genetics and Molecular Biology49.5%
    2. Immunology and Microbiology00.9%
    3. Neuroscience00.4%
    4. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Engineering13.1%
    2. Mathematics12.2%
    3. Computer Science00.8%
    4. Physics and Astronomy00.7%
    5. Chemical Engineering00.4%
    6. Materials Science00.2%
    7. Chemistry00.2%
    8. Earth and Planetary Sciences00.2%
    9. Environmental Science00.1%
    1. Social Sciences13.3%
    2. Psychology00.8%
    3. Economics, Econometrics and Finance00.6%
    4. Business, Management and Accounting00.4%
    5. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.96× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.95× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.11× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.35× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.28× its world share, 0 worksEarth and Planetary …Engineering: 0.14× its world share, 0 worksEngineeringPhysics and Astronomy: 0.25× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.44× its world share, 0 worksHealth ProfessionsMedicine: 4.01× its world share, 12 worksMedicineNursing: 1.14× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.09× its world share, 0 worksEconomics, Econometr…Psychology: 0.78× its world share, 0 worksPsychologySocial Sciences: 0.22× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Medicine4.01×12 works
  2. Pharmacology, Toxicology and Pharmaceutics2.11×0 works
  3. Biochemistry, Genetics and Molecular Biology1.96×2 works
  4. Nursing1.14×0 works
  5. Immunology and Microbiology0.95×0 works
  6. Psychology0.78×0 works
  7. Health Professions0.44×0 works
  8. Chemistry0.35×0 works
  9. Earth and Planetary Sciences0.28×0 works
  10. Physics and Astronomy0.25×0 works
  11. Social Sciences0.22×0 works
  12. Engineering0.14×0 works
  13. Economics, Econometrics and Finance0.09×0 works

Who are the top researchers at Utah Cancer Specialists?

Ranked on the quality score, W. Graydon Harker, Graydon Harker and Xylina T. Gregg lead among researchers whose main affiliation is Utah Cancer Specialists.

  1. 1 W. Graydon Harker United States · #252,906 worldwide 3.3k citations · 40 works
  2. 2 Graydon Harker United States · #964,244 worldwide 2.2k citations · 19 works
  3. 3 Xylina T. Gregg United States · #2,255,521 worldwide 600 citations · 21 works
All ranked researchers at Utah Cancer Specialists

What are the most cited papers from Utah Cancer Specialists?

The most cited paper from Utah Cancer Specialists is "Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study" (Ghassan K. Abou‐Alfa et al., 2020), with 1,117 citations. Next come "Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (569) and "Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation" (503).

Most cited papers
#PaperReleasedCitations
1 Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study Ghassan K. Abou‐Alfa et al. · The Lancet Oncology Open access 13 May 2020 1,117
2 Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan et al. · The Lancet Oncology 12 Feb 2016 569
3 Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation Andrew Xiuxuan Zhu et al. · JAMA Oncology Open access 23 Sep 2021 503
4 Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer Adam Brufsky, W. Graydon Harker, Joseph Thaddeus Beck et al. · Journal of Clinical Oncology Open access 12 Dec 2006 321
5 Impact of Time-of-Flight on PET Tumor Detection D.J. Kadrmas, Michael Casey, Maurizio Conti et al. · Journal of Nuclear Medicine Open access 17 Jul 2009 282
All 60 most cited papers, with filters and sorting

Which keywords describe research at Utah Cancer Specialists?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Breast Cancer, Clinical Practice Guidelines, Epidemiology, Clinical Trials, Surgical Management and Prognosis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Chemotherapy5▲ 16×18 topics
  2. Epidemiology4▲ 2.2×23 topics
  3. Prognostic Factors3▲ 14×11 topics
  4. Breast Cancer2▲ 20×8 topics
  5. Clinical Practice Guidelines2▲ 8.7×9 topics
  6. Inflammation2▲ 2.1×11 topics
  7. Cancer2▲ 3.1×14 topics
  8. Clinical Trials2▲ 6.7×8 topics
  9. Quality of Life2▲ 2.7×11 topics
  10. Immunotherapy2▲ 5.3×12 topics
  11. Surgical Management2▲ 7.5×7 topics
  12. Genetic Mutations1▲ 6.0×10 topics
  13. Oxidative Stress1▲ 1.69×7 topics
  14. Prognosis1▲ 9.8×3 topics
  15. Aging1▲ 5.4×4 topics
  16. Apoptosis1▲ 7.4×5 topics
  17. Cancer Treatment1▲ 11×4 topics
  18. Magnetic Resonance Imaging1▲ 7.7×4 topics
  19. Metabolic Syndrome1▲ 3.0×7 topics
  20. Neurotoxicity1▲ 15×2 topics
  21. Prevention1▲ 6.6×5 topics
  22. Survival Analysis1▲ 9.9×5 topics
  23. Targeted Therapy1▲ 12×4 topics
  24. Treatment1▲ 2.1×10 topics
  25. Cancer Cachexia1▲ 41×1 topic
  26. Genetic Variants1▲ 12×4 topics
  27. Global Access1▲ 44×2 topics
  28. Precision Medicine1▲ 8.3×5 topics
  29. Rituximab1▲ 15×3 topics
  30. Sarcopenia1▲ 41×1 topic
  31. COVID-19 Vaccine1▲ 57×1 topic
  32. Cancer Therapy1▲ 3.6×6 topics
  33. Engineering Students1▲ 435×1 topic
  34. Mathematics Support1▲ 435×1 topic
  35. Metastatic Breast Cancer1▲ 35×2 topics
  36. Vaccine Hesitancy1▲ 64×1 topic

Which research topics does Utah Cancer Specialists publish most on?

By volume in 2022-now: Nutrition and Health in Aging, Gout, Hyperuricemia, Uric Acid, Sarcoma Diagnosis and Treatment and Meningioma and schwannoma management.

Nutrition and Health in …1Nutrition and Health in Aging: 1 fractional worksGout, Hyperuricemia, Uric Acid: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksMeningioma and schwannoma management: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksBlood disorders and treatments: 0 fractional worksSoft tissue tumors and t…0Soft tissue tumors and treatment: 0 fractional worksSoft tissue tumor case studies: 0 fractional worksShoulder and Clavicle Injuries: 0 fractional worksNeutropenia and Cancer I…0Neutropenia and Cancer Infections: 0 fractional works
PhysiologyNephrologyPulmonary and Respiratory MedicineEpidemiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nutrition and Health in Aging Physiology 1 works
  2. 2 Gout, Hyperuricemia, Uric Acid Nephrology 0 works
  3. 3 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  4. 4 Meningioma and schwannoma management Epidemiology 0 works
  5. 5 PARP inhibition in cancer therapy Oncology 0 works
  6. 6 Blood disorders and treatments Genetics 0 works
  7. 7 Soft tissue tumors and treatment Pathology and Forensic Medicine 0 works
  8. 8 Soft tissue tumor case studies Rheumatology 0 works
  9. 9 Shoulder and Clavicle Injuries Epidemiology 0 works
  10. 10 Neutropenia and Cancer Infections Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 40% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 18% is written across borders.

How has Utah Cancer Specialists's research output changed?

Output in 2022-2025 was 86% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Utah Cancer Specialists as a percentage of every work published that year, 0.000054% in 2024.

still counting0.000050%0.00010%0.00015%Utah Cancer Specialists0.000069% in 20251990200020102020

Fractional works of Utah Cancer Specialists over all fractional works that year. How the balance of science has shifted.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Utah Cancer Specialists. Posts are plain text and can be reported.